Early robust NK cell immune recovery predicts outcomes after T cell–replete HSCT.
NK cell count > 150 cells/µL on day 30 is associated with improved OS and less TRM.
Low NK cell counts are associated with occurrences of bacterial and viral infections.
Low NK cell counts are associated with increased risk of CMV reactivation.